Intra-Cellular Therapies, Inc.
Updated Filing received by DOL
Intra-Cellular Therapies, Inc., a professional & technical services employer in Bedminster, New Jersey, reported 874 participants in its health and welfare plan for plan year 2025. Its Form 5500 shows 4 insurance contracts with no premium reported and $70,746 in broker commissions and fees. The plan is a mix of insured and self-funded coverage. The Department of Labor received the filing on June 26, 2026, before the deadline.
Who was paid on Intra-Cellular Therapies, Inc.'s plan
Schedule A, Part I lists each broker or agent paid on each insurance contract and the amount. Totals below add every contract Intra-Cellular Therapies, Inc. filed for 2025.
| Broker or agent | Commissions | Fees | Total | Contracts |
|---|---|---|---|---|
| Lockton · Boston, MA | $70,573 | $173 | $70,746 | 3 |
Source: DOL Form 5500 Schedule A, Part I (broker commissions and fees), plan year 2025, as published in EBSA's 2025 "Latest" dataset. Part I names whoever the carrier paid, which can be a firm or an individual agent; both are public record. Amounts exclude pay from carriers not tied to a listed contract.
Insurance contracts and carriers
Every insurance contract reported on Schedule A: carrier, what it covers, people covered at year end, earned premium, and broker compensation.
| Carrier · coverage | Covered | Premium | Broker pay | Rate |
|---|---|---|---|---|
| Aetna Life Insurance Companyhealth, dental, vision, prescription drug | 2,539 | — | $173 | — |
| Legalplans, USAcoverage not coded | 162 | — | $5,378 | — |
| Provident Life and Casualty Insurance Companycoverage not coded | 286 | — | — | — |
| Unum Life Insurance Company of Americalife, short-term disability, long-term disability | 1,089 | — | $65,195 | — |
Source: DOL Form 5500 Schedule A, plan year 2025. Self-funded medical coverage has no premium; amounts shown for it are stop-loss or administrative contracts.
How Intra-Cellular Therapies, Inc. compares
Medians across employers for plan year 2024, the most recent complete year. Commission rates use fully insured medical contracts only; dollar medians use every employer that disclosed broker pay.
Not computable: no insured medical premium on the filing.
Source: BenefitsLedger benchmarks from 58,547 employer health plans with 100 or more participants, plan year 2024. Methodology.
Year over year
| 2024 | 2025 | Change | |
|---|---|---|---|
| Participants | 610 | 874 | +43.3% |
| Premiums filed | $0 | $0 | not comparable |
| Broker commissions + fees | $73,410 | $70,746 | −3.6% |
| Commission rate | — | — | — |
Source: DOL Form 5500 filings for plan years 2024 and 2025.
Filings and timeliness
Plans this employer filed under its EIN with a health benefit code. Large plans are due seven months after the plan year ends, or two and a half months later with an extension; amended filings carry the amendment date, so no timing is asserted for them.
| Plan | Plan year end | Received by DOL | Timing | Participants |
|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. Flexible Benefits Plan#505 · final filing · insurance, general assets | December 31, 2025 | June 26, 2026 | before deadline | 874 |
Source: DOL Form 5500 Part I and signature dates; "late" means received after the extended deadline (the 15th day of the tenth month after plan year end). What a late Form 5500 costs.
How much did Intra-Cellular Therapies, Inc. pay in health insurance broker commissions in 2025?
Intra-Cellular Therapies, Inc.'s 2025 Form 5500 reports $70,746 in broker commissions and fees across 4 insurance contracts ($70,573 in commissions, $173 in fees), with Lockton receiving the largest share.
Is Intra-Cellular Therapies, Inc.'s health plan self-funded or fully insured?
The 2025 filing indicates the plan is a mix of insured and self-funded coverage. Medical coverage is written by Aetna Life Insurance Company.
How does Intra-Cellular Therapies, Inc.'s broker compensation compare with similar employers?
A commission-to-premium ratio cannot be computed for Intra-Cellular Therapies, Inc. because the filing does not report medical premium on Schedule A (usual for self-funded plans). In dollars, employers with 500-999 participants that disclosed broker pay reported a median of $104,902.
Send the full findings to your inbox.
A specialist writes up every finding for Intra-Cellular Therapies, Inc. with the methodology and public-source citations, in a form you can forward to your CFO or counsel. Tick the box if you also want a 15-minute walkthrough call.
We don't sell your email. By submitting, you agree that BenefitsLedger and its benefits advisory partner, WellthCare, may email or call you about these findings. Opt out anytime by replying. See our privacy policy.
Record built October 24, 2026 from U.S. Department of Labor, EBSA Form 5500 datasets (2025, 2024, 2023 plan years, 'Latest' files). Filings can run 7 to 10 months behind the plan year; always confirm against current plan documents. BenefitsLedger is not affiliated with the U.S. Department of Labor. Open the DOL filing search.